Clinical Scorecard: When Growth Comes From Trading Up, Not Showing Up
At a Glance
| Category | Detail |
|---|---|
| Condition | Market dynamics in the optical industry |
| Key Mechanisms | Shift towards value-driven decision-making among consumers |
| Target Population | Eyecare providers and consumers in the optical market |
| Care Setting | Eyecare practices |
Key Highlights
- US optical market value reached $69.5 billion in 2025, up 4.4% year over year
- Declines in patient visits and product volume despite increased spending
- Consumers are willing to trade up for perceived benefits
- Replacement cycles lengthened for patients without vision benefits
- Sunglasses category saw both value and unit volume growth
Guideline-Based Recommendations
Diagnosis
- Assess patient needs and preferences to guide product recommendations
Management
- Focus on value-driven conversations and curated product options
Monitoring & Follow-up
- Track patient spending patterns and preferences over time
Risks
- Potential for decreased patient visits impacting revenue
Patient & Prescribing Data
Patients in the US optical market
Patients are selective about spending, opting for premium options when benefits are clear
Clinical Best Practices
- Anchor conversations in patient values
- Present fewer, well-defined options
- Make upgrades tangible with demonstrations and comparisons
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.